All News

Strategic tips for pharma to develop an overall business strategy around digital engagement.

Trastuzumab-dkst (Ogivri) is the second biosimilar approved for cancer.

Patients with a partner were nearly twice as likely to finish 6 months of chemotherapy for colon cancer.

Nearly 21 million individuals with HIV had access to antiretroviral therapy (ART) in June 2017 compared to 685,000 HIV-positive patients in 2000.

Twenty-five states can participate in value-based insurance designs for Medicare Advantage plans in 2019.

Rising cancer drug costs have become inreasingly worrisome for patients and health care providers. Despite the entry of competitors in the market, treatment costs continue to climb over time, according to a study recently published by the Journal of Clinical Oncology.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

A look at last week's top stories in the world of pharmacy.

The FDA approves the first monthly injectable buprenorphine for opioid use disoder.

Raltegravir (Isentress) is an integrase inhibitor for use in combination with other antiretroviral agents for HIV-1 in newborn infants weighing at least 2 kg.

The FDA has approved Indivior’s Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use disorder (OUD).

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

With Midyear approaching, many are dreaming of finding that perfect program. Now is the time to start coming up with a game plan.

A report suggests Amazon may be selling improperly marketed supplements and medical devices.

Millions of individuals gain access to HIV treatment, but there are significant gaps that need to be addressed to end the epidemic.

Patients with severe psoriasis were 64% more likely to develop diabetes than control patients.

A new system allows researchers to test multiple drug combinations in cultured cancer stem cells from patients.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Synthetic cannabis-like therapy dronabinol associated with a lower overall apnea/hypopnea index compared with placebo.

Multiple sclerosis researchers actively seek new agents than can promote repair and remyelination.

In a world where we are bombarded with various diets, what does the evidence say?

New Hampshire is seeking to join the list of states allowing pharmacists to provide contraception to women without a prescription.

Is there a way to maintain these services in a cost-effective way so that all stakeholders benefit?

Apple announces a study to investigate whether their Apple Watch can detect afib in patients.

The FDA has extended the approval of raltegravir (Isentress, Merck), an integrase inhibitor for use in combination with other antiretroviral agents, for the treatment of HIV-1 in newborn infants weighing at least 2 kg.

Americans are getting tested and diagnosed with HIV sooner after infection, according to a recently-published CDC Vital Signs report.

An infant’s sex-specific gut microbiome following maternal asthma during pregnancy may influence their risk of developing childhood asthma.